Clyburn Frank 4
4 · Revolution Medicines, Inc. · Filed Jun 30, 2025
Insider Transaction Report
Form 4
Clyburn Frank
Director
Transactions
- Award
Common Stock
2025-06-26+2,806→ 9,738 total - Award
Stock Option (Right to Buy)
2025-06-26+10,337→ 10,337 totalExercise: $37.48Exp: 2035-06-26→ Common Stock (10,337 underlying)
Footnotes (2)
- [F1]Includes 8,005 Restricted Stock Units.
- [F2]Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.